Top news of the week: 15.07.2021.
Career And Jobs
BioSpace Movers & Shakers, July 9
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Founder Shield: Navigating Biotech Risks from Discovery to Approval
Up and down the development pipeline, there are vulnerabilities. From shareholder expectations and IP protection to clinical trial risk and cyberattacks, it’s a minefield and enlisting a ...
Biopharma transformed
Five ways the pandemic is going to revolutionise our industry
BRAIN Biotech AG: Additional CRISPR Genome Editing Nucleases Identified
DGAP-News: BRAIN Biotech AG / Key word(s): Miscellaneous15.07.2021 / 11:00 The issuer is solely responsible for the content of this announcement.Zwingenberg (Germany), July 15th, ...
Biogen taps Chinese biotech InnoCare in $125M midstage MS drug pact
Biogen is paying $125 million upfront to work on InnoCare’s orelabrutinib, an oral, small-molecule Bruton’s tyrosine kinase inhibitor that the pair hopes can cut it in multiple sclerosis.
Ribon, backed by biopharma majors, raises $65M to take PARP7 inhibitor deeper into the clinic
Ribon Therapeutics has raised $65 million to advance a pipeline led by a PARP7 inhibitor deeper into the clinic. The financing positions Ribon to build on work to target stress support ...
Chicago Biopharma Builds Commercial Facility in China to Focus on Antibody Development
Sparx Therapeutics is expanding its operations into Yangzhou, China, with the imminent construction of a 1.2 million square foot facility for its commercial production.
Biotech Uncloaks Primed for 'Search and Replace' Gene Editing with $315 Million
The company's technology aims to precisely search out genetic mutations at their precise genome location, limiting concerns about toxicities or unwanted cellular changes.